✦ LIBER ✦

Management of hepatitis B in patients coinfected with the human immunodeficiency virus

✍ Scribed by R. Lessells; C. Leen

Publisher: Springer
Year: 2004
Tongue: English
Weight: 136 KB
Volume: 23
Category: Article
ISSN: 0934-9723
DOI: 10.1007/s10096-004-1127-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis C virus genetic variability in

Hepatitis C virus genetic variability in 52 human immunodeficiency virus-coinfected patients

✍ Didier Neau; Anne-Christine Jouvencel; Elisabeth Legrand; Pascale Trimoulet; Tat 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 1 views

## Abstract The aim of this study was to examine whether hepatitis C virus (HCV) pretreatment quasispecies complexity was linked to virological response or other clinical and biological parameters, in human immunodeficiency virus (HIV)‐coinfected patients undergoing anti‐HCV treatment. In addition,

Liver fibrosis progression in human immu

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients

✍ Yves Benhamou; Marie Bochet; Vincent Di Martino; Frederic Charlotte; Felipe Azri 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 1 views

The natural history of hepatitis C virus (HCV) infection in human immunodeficiency virus (HIV)-infected patients has never been studied according to the concept of liver fibrosis progression. The aim of this work was to assess the fibrosis progression rate in HIV-HCV coinfected patients and in patie

Multinodular polymyositis in a patient w

Multinodular polymyositis in a patient with human immunodeficiency and hepatitis C virus coinfection

✍ Scot J. Richardson; Fred Lopez; Scott Rojas; Sungho Cho; Mark Holodniy; Brian He 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB 👁 2 views

Hepatic steatosis in patients coinfected

Hepatic steatosis in patients coinfected with human immunodeficiency virus/hepatitis C virus: A meta-analysis of the risk factors

✍ Mariana Verdelho Machado; António Gouveia Oliveira; Helena Cortez-Pinto 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 262 KB 👁 1 views

Hepatic steatosis (HS) is frequent in patients with hepatitis C virus (HCV) infection, occurring in 40%-80%, associating with metabolic and virus-related factors, namely, genotype 3 and viral load. Human immunodeficiency virus (HIV) infection and antiretroviral treatment seem to be risk factors for

Spontaneous clearance of hepatitis C vir

Spontaneous clearance of hepatitis C virus after liver transplantation in two patients coinfected with hepatitis C virus and human immunodeficiency virus

✍ Vishal Bhagat; Julie A. Foont; Eugene R. Schiff; Arie Regev 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

Spontaneous resolution of chronic hepatitis C virus (HCV) infection is exceedingly rare and poorly understood. As HCV and human immunodeficiency virus (HIV) have shared routes of transmission, HCV coinfection is estimated to affect 15%-30% of the HIV-positive population. We report 2 patients with HC

Fast fibrosis progression between repeat

Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus

✍ Juan Macías; Juan Berenguer; Miguel A. Japón; José A. Girón; Antonio Rivero; Lui 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB 👁 2 views

A few studies have assessed the observed fibrosis progression between serial liver biopsies (LB) in human immunodeficiency virus (HIV) / hepatitis C virus (HCV)-coinfected patients. Approximately half of the patients progressed at least one fibrosis stage over a short period of time. The risk factor